butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C136H197BClIN28O18 — CID 161494402

IUPACbutan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
SMILESCC(C)(C)OC(=O)N(CC1CCOCC1)c1cc(Cl)nn2ccnc12.CC1(C)OB(c2ccc(C(=O)NC3CC3)cc2)OC1(C)C.CCC(C)N.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2ncc(-c3ccc(C(=O)NC4CC4)cc3)n2n1.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2ncc(I)n2n1.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2nccn2n1.CCC(C)Nc1cc(NCC2CCOCC2)c2ncc(-c3ccc(C(=O)NC4CC4)cc3)n2n1
InChIInChI=1S/C31H42N6O4.C26H34N6O2.C21H32IN5O3.C21H33N5O3.C17H23ClN4O3.C16H22BNO3.C4H11N/c1-6-20(2)33-27-17-25(36(30(39)41-31(3,4)5)19-21-13-15-40-16-14-21)28-32-18-26(37(28)35-27)22-7-9-23(10-8-22)29(38)34-24-11-12-24;1-3-17(2)29-24-14-22(27-15-18-10-12-34-13-11-18)25-28-16-23(32(25)31-24)19-4-6-20(7-5-19)26(33)30-21-8-9-21;1-6-14(2)24-18-11-16(19-23-12-17(22)27(19)25-18)26(20(28)30-21(3,4)5)13-15-7-9-29-10-8-15;1-6-15(2)23-18-13-17(19-22-9-10-26(19)24-18)25(20(27)29-21(3,4)5)14-16-7-11-28-12-8-16;1-17(2,3)25-16(23)21(11-12-4-8-24-9-5-12)13-10-14(18)20-22-7-6-19-15(13)22;1-15(2)16(3,4)21-17(20-15)12-7-5-11(6-8-12)14(19)18-13-9-10-13;1-3-4(2)5/h7-10,17-18,20-21,24H,6,11-16,19H2,1-5H3,(H,33,35)(H,34,38);4-7,14,16-18,21,27H,3,8-13,15H2,1-2H3,(H,29,31)(H,30,33);11-12,14-15H,6-10,13H2,1-5H3,(H,24,25);9-10,13,15-16H,6-8,11-12,14H2,1-5H3,(H,23,24);6-7,10,12H,4-5,8-9,11H2,1-3H3;5-8,13H,9-10H2,1-4H3,(H,18,19);4H,3,5H2,1-2H3
InChIKeyWFZXCDUHKGYIRC-UHFFFAOYSA-N
MW2685.42 g/mol
LogP25.00
Rot. Bonds37

About butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (PubChem CID 161494402) has the molecular formula C136H197BClIN28O18 and a molecular weight of 2685.42 g/mol. Its IUPAC name is butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide.

Molecular Properties

Compound Namebutan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
PubChem CID161494402
Molecular FormulaC136H197BClIN28O18
Molecular Weight2685.42 g/mol
Exact Mass2683.42
IUPAC Namebutan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
SMILESCC(C)(C)OC(=O)N(CC1CCOCC1)c1cc(Cl)nn2ccnc12.CC1(C)OB(c2ccc(C(=O)NC3CC3)cc2)OC1(C)C.CCC(C)N.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2ncc(-c3ccc(C(=O)NC4CC4)cc3)n2n1.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2ncc(I)n2n1.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2nccn2n1.CCC(C)Nc1cc(NCC2CCOCC2)c2ncc(-c3ccc(C(=O)NC4CC4)cc3)n2n1
InChIInChI=1S/C31H42N6O4.C26H34N6O2.C21H32IN5O3.C21H33N5O3.C17H23ClN4O3.C16H22BNO3.C4H11N/c1-6-20(2)33-27-17-25(36(30(39)41-31(3,4)5)19-21-13-15-40-16-14-21)28-32-18-26(37(28)35-27)22-7-9-23(10-8-22)29(38)34-24-11-12-24;1-3-17(2)29-24-14-22(27-15-18-10-12-34-13-11-18)25-28-16-23(32(25)31-24)19-4-6-20(7-5-19)26(33)30-21-8-9-21;1-6-14(2)24-18-11-16(19-23-12-17(22)27(19)25-18)26(20(28)30-21(3,4)5)13-15-7-9-29-10-8-15;1-6-15(2)23-18-13-17(19-22-9-10-26(19)24-18)25(20(27)29-21(3,4)5)14-16-7-11-28-12-8-16;1-17(2,3)25-16(23)21(11-12-4-8-24-9-5-12)13-10-14(18)20-22-7-6-19-15(13)22;1-15(2)16(3,4)21-17(20-15)12-7-5-11(6-8-12)14(19)18-13-9-10-13;1-3-4(2)5/h7-10,17-18,20-21,24H,6,11-16,19H2,1-5H3,(H,33,35)(H,34,38);4-7,14,16-18,21,27H,3,8-13,15H2,1-2H3,(H,29,31)(H,30,33);11-12,14-15H,6-10,13H2,1-5H3,(H,24,25);9-10,13,15-16H,6-8,11-12,14H2,1-5H3,(H,23,24);6-7,10,12H,4-5,8-9,11H2,1-3H3;5-8,13H,9-10H2,1-4H3,(H,18,19);4H,3,5H2,1-2H3
InChIKeyWFZXCDUHKGYIRC-UHFFFAOYSA-N
XLogP25.00
TPSA507.19 Ų
H-Bond Donors9
H-Bond Acceptors39
Rotatable Bonds37
Heavy Atoms185
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002685.42
LogP ≤ 525.00
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het_6_tetrazine(18)', 'substructure': 'N/A'}, {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide?
The IUPAC name of butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (CID 161494402) is butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide.
What is the SMILES notation for butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide?
The canonical SMILES for butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide is CC(C)(C)OC(=O)N(CC1CCOCC1)c1cc(Cl)nn2ccnc12.CC1(C)OB(c2ccc(C(=O)NC3CC3)cc2)OC1(C)C.CCC(C)N.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2ncc(-c3ccc(C(=O)NC4CC4)cc3)n2n1.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2ncc(I)n2n1.CCC(C)Nc1cc(N(CC2CCOCC2)C(=O)OC(C)(C)C)c2nccn2n1.CCC(C)Nc1cc(NCC2CCOCC2)c2ncc(-c3ccc(C(=O)NC4CC4)cc3)n2n1.
What is the InChIKey of butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide?
The InChIKey is WFZXCDUHKGYIRC-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H42N6O4.C26H34N6O2.C21H32IN5O3.C21H33N5O3.C17H23ClN4O3.C16H22BNO3.C4H11N/c1-6-20(2)33-27-17-25(36(30(39)41-31(3,4)5)19-21-13-15-40-16-14-21)28-32-18-26(37(28)35-27)22-7-9-23(10-8-22)29(38)34-24-11-12-24;1-3-17(2)29-24-14-22(27-15-18-10-12-34-13-11-18)25-28-16-23(32(25)31-24)19-4-6-20(7-5-19)26(33)30-21-8-9-21;1-6-14(2)24-18-11-16(19-23-12-17(22)27(19)25-18)26(20(28)30-21(3,4)5)13-15-7-9-29-10-8-15;1-6-15(2)23-18-13-17(19-22-9-10-26(19)24-18)25(20(27)29-21(3,4)5)14-16-7-11-28-12-8-16;1-17(2,3)25-16(23)21(11-12-4-8-24-9-5-12)13-10-14(18)20-22-7-6-19-15(13)22;1-15(2)16(3,4)21-17(20-15)12-7-5-11(6-8-12)14(19)18-13-9-10-13;1-3-4(2)5/h7-10,17-18,20-21,24H,6,11-16,19H2,1-5H3,(H,33,35)(H,34,38);4-7,14,16-18,21,27H,3,8-13,15H2,1-2H3,(H,29,31)(H,30,33);11-12,14-15H,6-10,13H2,1-5H3,(H,24,25);9-10,13,15-16H,6-8,11-12,14H2,1-5H3,(H,23,24);6-7,10,12H,4-5,8-9,11H2,1-3H3;5-8,13H,9-10H2,1-4H3,(H,18,19);4H,3,5H2,1-2H3.
What are the key properties of butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide?
butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide has a molecular weight of 2685.42 g/mol, XLogP of 25.00, 37 rotatable bonds, 9 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for butan-2-amine;4-[6-(butan-2-ylamino)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropylbenzamide;tert-butyl N-[6-(butan-2-ylamino)-3-[4-(cyclopropylcarbamoyl)phenyl]imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-[6-(butan-2-ylamino)-3-iodoimidazo[1,2-b]pyridazin-8-yl]-N-(oxan-4-ylmethyl)carbamate;tert-butyl N-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(oxan-4-ylmethyl)carbamate;N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide is sourced from PubChem (CID 161494402), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).